LBX2 and ovarian carcinoma: We next divided the patients' data included in this data set into LBX2‐AS1 high expression group and low expression group based on the LBX2‐AS1 expression levels in their ovarian cancer tissue specimens, and we compared the overall survival of these two groups of patients.